Cornercap Investment Counsel’s Globus Medical GMED Stock Holding History

Cornercap Investment Counsel’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,740	Closed	-$839K	–	633
2023 Q4	$839K	Sell	15,740 -562	-3%	-$27.4K	0.14%	304
2023 Q3	$809K	Buy	+16,302	New	+$912K	0.15%	307
2022 Q1	–	Sell	-13,205	Closed	-$953K	–	586
2021 Q4	$953K	Buy	+13,205	New	+$959K	0.14%	325
2020 Q2	–	Sell	-17,902	Closed	-$761K	–	438
2020 Q1	$761K	Buy	+17,902	New	+$884K	0.15%	225
2017 Q1	–	Sell	-49,930	Closed	-$1.24M	–	361
2016 Q4	$1.24M	Buy	+49,930	New	+$1.13M	0.21%	128

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Cornercap Investment Counsel's GMED Position: Q1 2024 in Review

Cornercap Investment Counsel sold out of Globus Medical (GMED) in Q1 2024, closing a stake of 15,740 shares — an estimated $839K sold.

Cornercap Investment Counsel first reported a position in GMED in Q4 2016 and held it in 5 quarters. The position peaked at $1.24M in Q4 2016. 439 funds tracked by Wall St. Rank hold GMED as of Q1 2024.

Cornercap Investment Counsel reported no remaining Globus Medical position as of Q1 2024 after selling out during the quarter.
Cornercap Investment Counsel sold 15,740 Globus Medical shares in Q1 2024, an estimated $839K.
Cornercap Investment Counsel first reported a position in Globus Medical in Q4 2016 and held it in 5 quarters.
Cornercap Investment Counsel's Globus Medical position peaked at $1.24M in Q4 2016.
439 funds tracked by Wall St. Rank held Globus Medical as of Q1 2024.

Based on Cornercap Investment Counsel's 13F filing for Q1 2024, filed 10 May 2024.